Marimed (MRMD) Gross Profit (2011 - 2026)

Marimed (MRMD) has 16 years of Gross Profit data on file, last reported at $15.3 million in Q1 2026.

• Gross Profit for Q1 2026 came in at $15.3 million, up 1.24% year-over-year; the trailing twelve-month figure through Mar 2026 was $58.2 million (down 5.31% YoY), and the FY2025 annual result was $57.9 million, down 7.56% from the prior year.
• Gross Profit climbed to $15.3 million in Q1 2026 per MRMD's latest filing, from $10.5 million in the prior quarter.
• Over five years, Gross Profit peaked at $17.3 million in Q4 2023 and troughed at $10.5 million in Q4 2025.
• A 5-year average of $15.6 million and a median of $16.2 million in 2022 frame the typical range for Gross Profit.
• The sharpest annual moves came in 2022 and 2024: Gross Profit rose 28.74% in 2022, then declined 26.92% in 2024.
• A 5-year view of Gross Profit shows it stood at $15.8 million in 2022, then grew by 9.52% to $17.3 million in 2023, then fell by 26.92% to $12.7 million in 2024, then decreased by 17.02% to $10.5 million in 2025, then soared by 45.46% to $15.3 million in 2026.
• Business Quant data shows MRMD's Gross Profit at $15.3 million in Q1 2026, $10.5 million in Q4 2025, and $16.4 million in Q3 2025.